ADR Term |
ADReCS ID |
ADR Frequency (FAERS)
|
ADR Severity Grade (FAERS)
|
ADR Severity Grade (CTCAE)
|
Neonatal respiratory failure | 18.04.17.003; 22.11.02.011 | 0.009276% | | Not Available |
Pulmonary valve stenosis | 02.07.04.005 | 0.004638% | | Not Available |
Pulmonary valve stenosis congenital | 03.07.05.016; 02.07.04.006 | 0.009276% | | Not Available |
Renal failure neonatal | 20.01.03.024; 18.04.01.019 | 0.009276% | | Not Available |
Small for dates baby | 18.04.02.002 | 0.018551% | | Not Available |
Ventricular hypoplasia | 03.07.11.003; 02.08.01.011 | 0.009276% | | Not Available |
Blood HIV RNA increased | 13.08.03.003 | 0.176239% | | Not Available |
Mitochondrial cytopathy | 14.11.02.008 | 0.009276% | | Not Available |
Mitochondrial DNA deletion | 14.11.02.006; 03.18.01.004 | 0.009276% | | Not Available |
Foetal cardiac disorder | 18.03.02.013; 02.01.01.016 | 0.001210% | | Not Available |
Mitochondrial DNA mutation | 14.11.02.007; 03.18.01.005 | 0.001210% | | Not Available |
Intrauterine infection | 18.03.03.007; 11.01.10.018 | 0.001815% | | Not Available |
Carnitine deficiency | 14.08.04.022 | 0.016233% | | Not Available |
Hepatitis B DNA assay positive | 13.08.03.018 | 0.006957% | | Not Available |
Escherichia infection | 11.02.10.004 | 0.004638% | | Not Available |
Viral load increased | 13.08.03.035 | 0.018551% | | Not Available |
Viral mutation identified | 13.08.03.036 | 0.208704% | | Not Available |
Bicuspid pulmonary valve | 03.07.05.004; 02.07.04.002 | 0.009276% | | Not Available |
Atrioventricular septal defect | 03.07.02.005; 02.04.02.029 | 0.009276% | | Not Available |
Persistent left superior vena cava | 24.03.03.038; 03.07.04.003 | 0.009276% | | Not Available |
Acute hepatitis C | 11.05.06.007; 09.01.09.011 | 0.006957% | | Not Available |
Virologic failure | 11.01.08.062; 08.06.01.034 | 0.322332% | | Not Available |
Hepatitis B DNA increased | 13.08.03.019 | 0.027827% | | Not Available |
Distributive shock | 24.06.02.022 | 0.004638% | | Not Available |
Infantile apnoea | 22.11.02.004; 18.04.15.003 | 0.009276% | | Not Available |
End stage renal disease | 20.01.03.019 | 0.004638% | | Not Available |